Congress Park Capital’s Celgene Corp CELG Stock Holding History

Congress Park Capital’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-10,513	Closed	-$1.04M	–	101
2019 Q3	$1.04M	Hold	10,513	–	–	0.88%	32
2019 Q2	$975K	Sell	10,513 -3,375	-24%	-$320K	0.77%	36
2019 Q1	$1.31M	Buy	13,888 +2,450	+21%	+$214K	1.13%	27
2018 Q4	$733K	Sell	11,438 -3,645	-24%	-$269K	0.81%	36
2018 Q3	$1.35M	Sell	15,083 -2,980	-16%	-$263K	1.21%	23
2018 Q2	$1.44M	Buy	18,063 +1,325	+8%	+$110K	1.38%	21
2018 Q1	$1.49M	Sell	16,738 -2,980	-15%	-$286K	1.53%	19
2017 Q4	$2.06M	Buy	+19,718	New	+$2.22M	2.07%	12

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Congress Park Capital's CELG Position: Q4 2019 in Review

Congress Park Capital sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 10,513 shares — an estimated $1.04M sold.

Congress Park Capital first reported a position in CELG in Q4 2017 and held it in 8 quarters. The position peaked at $2.06M in Q4 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Congress Park Capital reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Congress Park Capital sold 10,513 Celgene Corp shares in Q4 2019, an estimated $1.04M.
Congress Park Capital first reported a position in Celgene Corp in Q4 2017 and held it in 8 quarters.
Congress Park Capital's Celgene Corp position peaked at $2.06M in Q4 2017.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Congress Park Capital's 13F filing for Q4 2019, filed 31 Jan 2020.